Category

Daily Briefs

Daily Brief Macro: Fund Managers Are Long Commodities Again and more

By | Daily Briefs, Macro

In today’s briefing:

  • Fund Managers Are Long Commodities Again
  • Global FX: A Strong Dollar Is Not a US Problem
  • Fed Still Intent on Lowering Policy Rate Despite Inflation Uncertainties
  • The Week That Was in ASEAN@Smartkafarma – Medikaloka Hermina, Avian Paints, and Vinfast
  • Richmond Fed President Tom Barkin On Getting Inflation Under Control
  • The week at a glance: Time for the BoJ to step up, while soft PCE numbers may fool some..
  • Energy Cable: Inflation starting to bite equities
  • BoE Review: Uncomfortable Guidance


Fund Managers Are Long Commodities Again

By The Commodity Report

  • Fund Managers Are Long Commodities Again Be careful if you’re heavily long commodities at the moment.
  • The Bank of America survey usually always works as a great contra sentiment indicator.
  • If fund managers are heavily long commodities – prices tend to top out.

Global FX: A Strong Dollar Is Not a US Problem

By At Any Rate

  • Strong dollar not seen as a problem for the US or the Fed, more concerning for the rest of the world
  • Unlikely to see coordinated global intervention due to high hurdles and lack of exceptional circumstances
  • Dollar CNY stability due to PBOC holding it down, may welcome cooling pressures on the currency from Japan and Korea verbal interventions

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Fed Still Intent on Lowering Policy Rate Despite Inflation Uncertainties

By Said Desaque

  • Investors have become more hawkish about the outlook for Fed policy compared to Federal Open Market Committee (FOMC) members for the first time since the infamous taper tantrum in 2013
  • Engineering a policy pivot away from higher for longer rhetoric towards policy rate cuts will provide a communication challenge if sticky service sector inflation persists.
  • Profligate fiscal policy complicates the Fed’s prospective conduct. The required measures for sustainable fiscal policy are off-limits, raising the possibility of higher inflation to stabilise the debt-to-GDP ratio.    

The Week That Was in ASEAN@Smartkafarma – Medikaloka Hermina, Avian Paints, and Vinfast

By Angus Mackintosh


Richmond Fed President Tom Barkin On Getting Inflation Under Control

By Odd Lots

  • Inflation data has been hotter than expected, remaining stubbornly above 3%
  • Demand in the economy has been robust, with strong retail sales and job reports
  • Richmond Fed President Tom Barkin discusses potential factors influencing inflation and the need for offsetting housing strength in the economy

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


The week at a glance: Time for the BoJ to step up, while soft PCE numbers may fool some..

By Andreas Steno

  • Welcome to our weekly “the week at a glance” publication where we dissect the most important central bank meetings and key figure releases in a short and sweet format.
  • This week we focus on PCE prices, European PMIs and the Bank of Japan.
  • Event 1: European PMIs (Tues): A lukewarm, but positive, surprise.

Energy Cable: Inflation starting to bite equities

By Ulrik Simmelholt

  • Calmness returned to pockets of cross asset markets last week.
  • The long end of the US yield curve got off its highs, crude got back under USD 90 and equities are left as the only truly hurt asset with SPX dipping under 5k for the first time since Feb.
  • Month-to-date, Energy remains the only sector in green, underlining what we have been saying since the inception of this newsletter

BoE Review: Uncomfortable Guidance

By Phil Rush

  • Ben Bernanke’s review of forecasting at the Bank of England raised many suggestions. We hope the BoE doesn’t dodge two aspects critical to improving its guidance.
  • Inflation expectations are poorly captured in forecasts, contributing to misguided market views and leaving MPC members open to attack when critiquing surging wages.
  • MPC rate expectations would best replace the conditioning rate path. Absent that, market rates are better than alternatives so that path should not be de-emphasised.

Note: This is part of an external compendium of responses to the Bernanke review.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Bell Financial and more

By | Australia, Daily Briefs

In today’s briefing:

  • Bell Financial Group Ltd – Strong start to FY24 with Q1 PBT +60%


Bell Financial Group Ltd – Strong start to FY24 with Q1 PBT +60%

By Research as a Service (RaaS)

  • Bell Financial Group Ltd (ASX:BFG) is a diversified provider of financial products and software solutions within, and increasingly outside, its traditional full-service stockbroking business.
  • A Q1 FY24 trading update provided at the group’s AGM on 19 April points to revenue growth of 17% and PBT growth of 60% to $9.3m, with all divisions said to be profitable.
  • This compares to a RaaS H1 FY24 PBT growth estimate of 69%, placing the group on track to achieve our H1 estimates.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Korea Stock Exchange Kospi Index and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Significant Developments Emerged Today for Korea’s Value-Up


Significant Developments Emerged Today for Korea’s Value-Up

By Sanghyun Park

  • Deputy PM Choi Sang-mok commits to aggressively pursue separate taxation of dividend income, marking a shift towards concrete action for value-up policies.
  • Ever since the introduction of the Value-up policy earlier this year, the primary incentive championed by the local capital market has been the separate taxation of dividend income.
  • Hence, the government’s official commitment to this marks a crucial step in reshaping the Value-up momentum.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Indonesia: Pertamina Geothermal Energy PT and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • Morning Views Asia: Pertamina Geothermal Energy PT, Vedanta Resources


Morning Views Asia: Pertamina Geothermal Energy PT, Vedanta Resources

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: United States Steel and more

By | Daily Briefs, United States

In today’s briefing:

  • Nippon Steel/United States Steel Corp


Nippon Steel/United States Steel Corp

By Jesus Rodriguez Aguilar

  • On 18 April, a White House official said that any review of the deal between Nippon Steel Corporation (5401 JP) and United States Steel (X US) by CFIUS will continue as scheduled.
  • X shares trade at ~5.2x on NTM IBES-consensus EBITDA given priced-in deal risk vs. implied 7x at the time of the winning NSC’s bid, and look attractive relative to comparables.
  • There remains a possibility that Nippon could finalize the takeover after the U.S. presidential election, presenting potential upside.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: NIFTY Index, Pertamina Geothermal Energy PT and more

By | Daily Briefs, India

In today’s briefing:

  • EQD / NSE Volatility Update / 15-Apr-24 to 19-Apr-24
  • Morning Views Asia: Pertamina Geothermal Energy PT, Vedanta Resources


EQD / NSE Volatility Update / 15-Apr-24 to 19-Apr-24

By Sankalp Singh

  • Unprecedented levels of FII option-buying & increasing geo-political risk causing IVs to re-price higher.
  • Skew/ Smile characteristics of the Vol Surface reflect increased risk aversion but not it panic mode – yet.
  • BankNifty IVs exhibiting unusual “kink-in-the-curve”. Enter barbell structures to position for reversion in curve shape.

Morning Views Asia: Pertamina Geothermal Energy PT, Vedanta Resources

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Shinko Electric Industries, Kokusai Electric , Silver, Shift Inc, TSE Tokyo Price Index TOPIX and more

By | Daily Briefs, Japan

In today’s briefing:

  • Merger Arb Mondays (22 Apr) – Shinko, Inageya, C&F Logistics, Hollysys, Azure, Qantm IP, Tietto
  • ECM Weekly (22nd Apr 2024) – Kokusai, J&T, Voda IDEA, ChaPanda, Cloudchain, Johor Plant, Aadhar
  • Silver Measured Move to 35.50
  • Shift: On a Road to Recovery
  • Stricter Voting Criteria for Domestic Asset Managers May Aim to Enhance Value Through Engagement


Merger Arb Mondays (22 Apr) – Shinko, Inageya, C&F Logistics, Hollysys, Azure, Qantm IP, Tietto

By Arun George


ECM Weekly (22nd Apr 2024) – Kokusai, J&T, Voda IDEA, ChaPanda, Cloudchain, Johor Plant, Aadhar

By Sumeet Singh


Silver Measured Move to 35.50

By Douglas Busch

  • S&P 500 looks vulnerable. Maintain large cash positions for forseeable future.
  • US Dollar bull flagging and may put pressure on equities in near term.
  • Nikkei at inflection point. Bulls must stand up here to defend.

Shift: On a Road to Recovery

By Shifara Samsudeen, ACMA, CGMA

  • Shift Inc (3697 JP) ’s share price has been down more than 50% YTD with the release of 1QFY08/2024 results in January 2024 which saw a drop in margins.
  • The company’s aggressive investment in HR and system reinforcement led to a decline in margins, however, margins saw a QoQ improvement in 2QFY08/2024.
  • Despite there being an improvement in 2Q and the company expecting the margins to bounce back in 4Q, Shift’s share price has continued to fall.

Stricter Voting Criteria for Domestic Asset Managers May Aim to Enhance Value Through Engagement

By Aki Matsumoto

  • Stricter voting standards for domestic investment managers seem aimed at increasing value through engagement for companies that show little improvement in efforts to improve stock price and return on capital.
  • Stricter voting standards for policy shareholding ratios of domestic investment management companies are expected to push companies to consider reducing cross-shareholdings. Reference to deemed shareholdings is also commendable.
  • Since engagement of overseas investors has been effective in increasing value of companies, engagement by Japanese investment managers more seriously than before will contribute to enhancing the value of companies.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: JD.com , Innovent Biologics Inc, Shanghai Tofflon Science A, S.F. Holding, Xunfei Healthcare Technology, CanSino Biologics and more

By | China, Daily Briefs

In today’s briefing:

  • JD.com (JD US / 9618 HK):  Announced 2.8% Share Buyback In 1Q24 + My 1Q24 Preview
  • Innovent Biologics(1801 HK)– More than Just a GLP-1 Play
  • China Healthcare Weekly (Apr.21) – M&As in Biotech, Capital Is Bullish on Non-Tumor Sectors, Tofflon
  • Monthly Chinese Express Tracker | March ASPs Fell, Again | Volumes Moderated, Including X-Border
  • Xunfei Healthcare Technology Pre-IPO – Appears to Be in the Early Stages of Commercialization
  • CanSino Biologics (6185.HK/688185.CH) – 2024 Is the Best Time to Bottom-Fish This Stock


JD.com (JD US / 9618 HK):  Announced 2.8% Share Buyback In 1Q24 + My 1Q24 Preview

By Steve Zhou, CFA

  • JD.com (9618 HK) announced this week that it has repurchased 2.8% of the outstanding shares of the company in the first quarter of 2024. 
  • Improved shareholder returns is a key thesis for the stock, given that there is little market expectation on such given limited track record.
  • A positive catalyst on full year performance could be the government’s announced stimulus policy for home appliance in April this year (trading old for new).

Innovent Biologics(1801 HK)– More than Just a GLP-1 Play

By Avien Pillay

  • Innovent is most well-known as the developer of mazdutide in China, however this is overshadowing a strong portfolio of oncology drugs in a very high growth market.
  • China’s approach to healthcare is being defined by having the biggest diabetic population, over 4 million new cancer cases per year, and over 100 million living with obesity.
  • We expect the valuation gap between the two first-to-market GLP-1 drugs, and competition to close. Oncology drug sales and valuations will continue its growth trajectory.

China Healthcare Weekly (Apr.21) – M&As in Biotech, Capital Is Bullish on Non-Tumor Sectors, Tofflon

By Xinyao (Criss) Wang

  • We have seen four transactions of MNC acquiring Chinese Biotech companies. However, this does not mean that domestic big pharmaceutical companies will also participate in the acquisition of small Biotech.
  • The underlying investment logic of innovative drug is undergoing changes. Non-oncology fields, such as autoimmunity, CNS, endocrine metabolism, and ophthalmology will be the main hot directions of investment and R&D.
  • Shanghai Tofflon Science A (300171 CH) is still in downward trend. We’re not optimistic about its 2023 results. We don’t recommend bottom-fish this stock unless there is a major catalyst.

Monthly Chinese Express Tracker | March ASPs Fell, Again | Volumes Moderated, Including X-Border

By Daniel Hellberg

  • ASPs remain under pressure as STO, J&T gain volume share in ground segment
  • March showed a surprising slowdown in pace of international volume growth
  • We believe Q423 and Q124 company-level profitability will mostly disappoint

Xunfei Healthcare Technology Pre-IPO – Appears to Be in the Early Stages of Commercialization

By Clarence Chu

  • Xunfei Healthcare Technology (XHT HK) is looking to raise around US$200m in its upcoming Hong Kong IPO.
  • Xunfei Healthcare Technology (Xunfei), a iFlytek (Shenzhen-listed) spin-off, primarily provides solutions covering the full healthcare service cycle, with products and services mainly catered towards major stakeholders in the healthcare industry.
  • In this note, we look at the firm’s past performance.

CanSino Biologics (6185.HK/688185.CH) – 2024 Is the Best Time to Bottom-Fish This Stock

By Xinyao (Criss) Wang

  • We would see CanSino’s performance pick up obviously in 2024 – Revenue of meningococcal vaccines would up about 50% YoY. Both R&D and SG&A expenses would show a declining trend.
  • Starting from 2025, CanSino’s product matrix will become more diverse.Its financial performance will enter a virtuous cycle. Revenue in 2025 may exceed expectations, depending on the approval time of PCV13i.
  • CanSino is one of the few domestic vaccine companies that has ability to explore the international market. Mispricing/expectation differences in the market will give investors the opportunity for excess returns.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: S.F. Holding and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Monthly Chinese Express Tracker | March ASPs Fell, Again | Volumes Moderated, Including X-Border


Monthly Chinese Express Tracker | March ASPs Fell, Again | Volumes Moderated, Including X-Border

By Daniel Hellberg

  • ASPs remain under pressure as STO, J&T gain volume share in ground segment
  • March showed a surprising slowdown in pace of international volume growth
  • We believe Q423 and Q124 company-level profitability will mostly disappoint

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Utilities: Pertamina Geothermal Energy PT and more

By | Daily Briefs, Utilities Sector

In today’s briefing:

  • Morning Views Asia: Pertamina Geothermal Energy PT, Vedanta Resources


Morning Views Asia: Pertamina Geothermal Energy PT, Vedanta Resources

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars